StockData
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.95−0.09 (-4.41%)

Close on Nov 17, 2026Market cap $2.94MP/E –Yield –

Apimeds Pharmaceuticals US price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Apimeds Pharmaceuticals US's price to book ratio was 0.0× on Nov 11, 2026, against 4.5× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.0×−2.5
2025Dec 31, 20252.5×–

More Apimeds Pharmaceuticals US figures

See a number that looks wrong?